Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile
Therapeutic Advances in Neurological Disorders

@taneuroldisord

A leading gold #OpenAccess journal in clinical neurology | IF 4.7 CiteScore 9.0 | 🧠 Follow us for neurological research and news.

ID: 1088444597775228931

linkhttp://journals.sagepub.com/home/tana calendar_today24-01-2019 14:33:09

760 Tweet

649 Followers

633 Following

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

A patient perspective on the #ALS "moonshot" to transform ALS from a fatal condition to a manageable, chronic disease calls for better defining ALS subtypes to enable precision therapies, addressing TDP43 malfunction, and R&D innovations. statnews.com/2024/06/30/als…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🚀 Early Career Researchers, this one's for you! 🌱 If you're interested in Editorial Board membership but unsure of the steps, start here. Our guide will help you navigate your journey. us.sagepub.com/en-us/nam/ecrs…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

A mouse study published in Science suggests that temporarily altered content of spinal fluid that follows abnormal neuronal inactivity is a trigger for #migraine pain: nature.com/articles/d4158…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🧠 New Delphi panel insights on cenobamate use in epilepsy treatment! Discover best practices for managing adverse events and improving patient outcomes. Study by Jukka Peltola, Rhys Thomas & team: journals.sagepub.com/doi/full/10.11… #EpilepsyResearch #Cenobamate #NeuroScience

🧠 New Delphi panel insights on cenobamate use in epilepsy treatment! Discover best practices for managing adverse events and improving patient outcomes. Study by <a href="/jukka_nekujupe/">Jukka Peltola</a>, <a href="/Dr_Rhys/">Rhys Thomas</a> &amp; team: journals.sagepub.com/doi/full/10.11…

#EpilepsyResearch #Cenobamate #NeuroScience
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🎓 EBMs with teaching and mentoring responsibilities, Sage offers a suite of resources to support your role. From classroom to research, find the tools you need for success. us.sagepub.com/en-us/nam/ebms…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

Could CAR-T immune therapy hold promise for treating #glioma? Find out more in this news piece: nature.com/articles/d4158… #glioblastoma #BrainCancer #CART

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

✨ Why choose Sage? Our active Editorial Board Members enjoy numerous rewards, including partnerships with Web of Science, book discounts, free journal access, and more. Explore the benefits: us.sagepub.com/en-us/nam/rewa…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🎓 Did you miss our recent "How to Do Research and Get Published" webinar? Learn from the best with insights from Dr. Babalola Faseru (Babalola Faseru) and Dr. Gilbert Gee (Gilbert Gee). Catch the full recording now: youtube.com/watch?v=-IMNEo…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

📢 August is #SMAAwarenessMonth! We're proud to stand with Spinal Muscular Atrophy UK and celebrate the uniqueness of the SMA community. Let's uplift voices, share experiences, and raise awareness together. Learn more and support here: smauk.org.uk/advocacy-and-c… #IAmUnique #SupportSMA

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🌟Read this article on the comparative effectiveness and safety of #ozanimod vs other oral DMTs in relapsing-remitting multiple sclerosis. Discover the insights from matching-adjusted indirect comparisons! journals.sagepub.com/doi/full/10.11… By: Marisa McGinley, Akanksha Sharma MD and team

🌟Read this article on the comparative effectiveness and safety of #ozanimod vs other oral DMTs in relapsing-remitting multiple sclerosis. Discover the insights from matching-adjusted indirect comparisons! journals.sagepub.com/doi/full/10.11…

By: <a href="/MarisaMcginley/">Marisa McGinley</a>, <a href="/AkankshaMD/">Akanksha Sharma MD</a> and team
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🧠 Cenobamate for epilepsy: Expert Delphi panel provides key recommendations for treatment initiation. Addressing drug interactions and patient support. Explore the details: journals.sagepub.com/doi/full/10.11… Authored by: Rhys Thomas, Jukka Peltola and team #EpilepsyTreatment #Cenobamate

🧠 Cenobamate for epilepsy: Expert Delphi panel provides key recommendations for treatment initiation. Addressing drug interactions and patient support. Explore the details: journals.sagepub.com/doi/full/10.11…

Authored by: <a href="/Dr_Rhys/">Rhys Thomas</a>, <a href="/jukka_nekujupe/">Jukka Peltola</a> and team

#EpilepsyTreatment #Cenobamate
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🌟 Early Career Researchers! Take the first steps towards joining an Editorial Board with our Sage Editorial Board Member Hub. Learn how peer reviewing and publishing can pave the way for your academic journey. Explore more: us.sagepub.com/en-us/nam/edit… #AcademicResearch #Neurology

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

💉 Exploring #eculizumab's role in myasthenic crisis: This prospective case series shows promising results in weaning from ventilatory support and reducing disease activity in refractory #MyastheniaGravis patients. Read more on the safety and efficacy: journals.sagepub.com/doi/full/10.11…

💉 Exploring #eculizumab's role in myasthenic crisis: This prospective case series shows promising results in weaning from ventilatory support and reducing disease activity in refractory #MyastheniaGravis patients. Read more on the safety and efficacy: journals.sagepub.com/doi/full/10.11…
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

📅 We're halfway through #SMAAwarenessMonth! To further support SMA research, we're offering a special discount for submissions on SMA. Interested? Email [email protected] for details. 🔗 Learn more: smauk.org.uk/advocacy-and-c… #IAmUnique #SupportSMA

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🧬 Exploring rare adverse effects: This case report highlights a unique instance of transient #hyperCKaemia following #inebilizumab therapy in a patient with #NMOSD. Learn more about this rare reaction and its management: journals.sagepub.com/doi/full/10.11… #Neurology #NMOSD

🧬 Exploring rare adverse effects: This case report highlights a unique instance of transient #hyperCKaemia following #inebilizumab therapy in a patient with #NMOSD. Learn more about this rare reaction and its management: journals.sagepub.com/doi/full/10.11…

#Neurology #NMOSD
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🧠🔬 New study reveals that eccentric muscle training doesn't impact cytokine levels in people with multiple sclerosis, suggesting it's safe for rehabilitation without triggering inflammation. Dive into the findings here: journals.sagepub.com/doi/10.1177/17… #MSResearch #Rehabilitation

🧠🔬 New study reveals that eccentric muscle training doesn't impact cytokine levels in people with multiple sclerosis, suggesting it's safe for rehabilitation without triggering inflammation. Dive into the findings here: journals.sagepub.com/doi/10.1177/17…

#MSResearch #Rehabilitation
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

🚨 Delirium affects up to 35% of stroke patients, impacting recovery and outcomes. The Austrian Stroke Society's latest position paper provides vital strategies for effective management. Learn more: journals.sagepub.com/doi/full/10.11… #StrokeAwareness #DeliriumManagement #PatientCare

🚨 Delirium affects up to 35% of stroke patients, impacting recovery and outcomes. The Austrian Stroke Society's latest position paper provides vital strategies for effective management. Learn more: journals.sagepub.com/doi/full/10.11…

#StrokeAwareness #DeliriumManagement #PatientCare
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

Congratulations to Prof Kerstin Hellwig for winning the Rachel Horne Prize for Women's Research in #MultipleSclerosis! Prof Hellwig is currently coordinating a Special Collection on Women's Research in Neurology. Interested in contributing? Check it out: journals.sagepub.com/topic/collecti…

Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

📊 The association between vagal atrophy and autonomic dysfunction in MSA and PSP is explored in this new study, offering potential biomarkers for diagnosis. Co-authored by Editor in Chief Ralf Gold. Dive into the findings: journals.sagepub.com/doi/full/10.11… #MSA #PSP #NeurologyResearch

📊 The association between vagal atrophy and autonomic dysfunction in MSA and PSP is explored in this new study, offering potential biomarkers for diagnosis. Co-authored by Editor in Chief Ralf Gold. Dive into the findings: journals.sagepub.com/doi/full/10.11…

#MSA #PSP #NeurologyResearch
Therapeutic Advances in Neurological Disorders (@taneuroldisord) 's Twitter Profile Photo

📅September 7th is #WorldDuchenneAwarenessDay! Join us in raising awareness for Duchenne Muscular Dystrophy, a condition that affects so many lives worldwide. Let's unite and amplify the voices of those impacted by Duchenne. Get involved: worldduchenneday.org 🌍 World Duchenne Awareness Day 🎈

📅September 7th is #WorldDuchenneAwarenessDay! Join us in raising awareness for Duchenne Muscular Dystrophy, a condition that affects so many lives worldwide. Let's unite and amplify the voices of those impacted by Duchenne. Get involved: worldduchenneday.org 🌍

<a href="/DuchenneDay/">World Duchenne Awareness Day 🎈</a>